hydralazine has been researched along with Spherocytosis, Hereditary in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Spherocytosis, Hereditary: A group of familial congenital hemolytic anemias characterized by numerous abnormally shaped erythrocytes which are generally spheroidal. The erythrocytes have increased osmotic fragility and are abnormally permeable to sodium ions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CLARK, TW | 1 |
| EWER, RW | 1 |
1 other study available for hydralazine and Spherocytosis, Hereditary
| Article | Year |
|---|---|
HEREDITARY SPHEROCYTOSIS AND POLYCYTHEMIA.
Topics: Ankyrins; Bloodletting; Chlorothiazide; Drug Therapy; Geriatrics; Humans; Hydralazine; Hypertension; | 1965 |